MMSI - Merit Medical Corp Long-Term Liabilities to Capital

Symbol and logo of brand Merit Medical Corp (MMSI)

Global sales for Merit Medical Systems (MMSI) are constrained by trade barriers and logistical disruptions in Asia. Microcatheter production relies on automation and machine control, although innovation remains dependent on engineering expertise. This price chart on GURU.Markets shows the metric at 0.50. Merit Medical Systems (MMSI) is successfully expanding its presence in cardiology, leveraging unique patents to protect margins and retain loyal customers.

Merit Medical Systems Inc (MMSI): Long-Term Debt to Capital from 07/04/2022 to 10/28/2026

Comprehensive metric breakdowns and analytics for Merit Medical Systems (MMSI)

- price and consensus price forecast:
Stock Quotes Merit Medical Systems, Inc.|MMSI - Analyst Consensus Forecast
- market capitalization data:
Market Value Merit Medical Systems, Inc.|MMSI - Enterprise Value
- book capitalization data:
Equity per Share Merit Medical|MMSI - Book Capitalization|Market Capitalization to Book Value merit.com|MMSI - Company Total Assets
- debt and liquidity data:
Total Debt to Equity Ratio Merit Medical Systems|MMSI - Long-Term Debt to Capital|Short-Term Debt to Capital merit.com|MMSI - Company Debts|Debt to Book Capitalization Ratio Merit Medical Systems, Inc.
Comprehensive company analysis:MMSI Merit Medical Systems, Inc.
Core merchandise of Merit Medical Systems

Merit Medical Systems' expansion into the minimally invasive instruments segment requires significant investment, making debt load control critical for business sustainability. The ratio of long-term liabilities to net assets allows for an assessment of the company's reliance on borrowed capital, while analyzing the level of long-term loans relative to equity helps investors distinguish strategic development from the risks of over-leverage.

Competitor analysis

Long-Term Debt to Equity Ratio Intuitive Surgical, Inc.|Danaher Corp - Long-Term Debt to Capital|Long-Term Liabilities to Capital Becton Dickinson & Company (BDX)|STE - Long-Term Debt to Capital|Long-Term Debt to Capital Ratio westpharma.com WST|Long-Term Debt to Capital BAX (Baxter)|MASI - Ratio of Long-Term Indebtedness to Capital|STVN (Stevanato) - Long-Term Debt to Capital|Teleflex Corp (TFX) - Long-Term Debt to Equity Ratio|NVST (Envista Holdings) - Long-Term Debt to Capital|Long-Term Debt to Capital ICUI|Long-Term Debt to Equity Dentsply Sirona (XRAY)|Long-Term Debt to Equity LeMaitre Vascular Inc LMAT|Long-Term Debt to Equity Ratio AtriCure Corp|Long-Term Debt to Capital Coefficient STAAR Surgical Co STAA|Long-Term Debt to Capital NAGE (ChromaDex Corp.)|ZIMV: Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity AngioDynamics|CERS (Cerus Corp.) - Long-Term Debt to Capital Ratio|TKNO: Long-Term Debt to Equity|Ratio of Long-Term Indebtedness to Capital Monogram Orthopedics Inc. (MGRM)|Long-Term Debt to Equity Ratio Sharps Technology, Inc.|Long-Term Loans to Capital Ratio INFU (infusystem.com)|Long-Term Debt to Equity Utah Medical Products, Inc.|KRMD - Long-Term Debt to Capital Coefficient|Nyxoah, S.A. - Long-Term Debt to Equity Ratio|MBOT: Long-Term Debt to Capital|PDEX (Pro-Dex, Inc.) - Long-Term Debt to Equity|zentek.com (ZTEK) - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital ELUT (Elutia)|Long-Term Liabilities to Capital MLSS|Long-Term Debt to Equity NEXGEL, Inc NXGL|Long-Term Debt to Capital Ratio retractable.com RVP|Long-Term Debt to Equity Ratio Harvard Bioscience, Inc. (HBIO)|femasys.com - Long-Term Loans to Capital Ratio|Long-Term Debt to Equity MHUA (Meihua Medical)|POAI: Ratio of Long-Term Indebtedness to Capital|CJMB (callanjmb.com) - Long-Term Debt to Equity|Atrion Corporation Inc. (ATRI) - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital NURO (NeuroMetrix, Inc.)